The ValiMed system is now operational at Henry Ford Hospital, a 903-bed tertiary care facility in Detroit, Mich. The system will perform end-product testing of compounded intravenous medication in the hospital's pharmacy department, as well as validation of returned narcotics in its operating room suites and nursing units. Developed by CDEX Inc, the ValiMed medication-verification system provides clinicians with a fast, cost-effective, and simple tool to further guarantee medication safety by validating that medications are properly compounded.
ValiMed works by using a patent-pending technology to verify compounded doses of high-risk medications before dispensing. The solution creates an additional level of safety in the medication-dispensing process, and it also is used to validate narcotic returns as well as to identify counterfeit medications.
"At Henry Ford, our top priority is patient safety," said Ed Szandzik, director of the hospital's pharmacy. "The ValiMed product strengthens our dispensing process by adding another level of safety to ensure [that] compounded medications are accurately verified and narcotic returns are properly handled in the pharmacy."
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs